Henderson Jeffrey William
SEC insider (Form 3/4/5 filer). CIK 0001324015. Director at HALOZYME THERAPEUTICS, INC. (HALO) and 2 other issuers. 18 reported Form 4/5 transactions since Sep 2024; latest on May 5, 2026. Located in SAN DIEGO, CA.
Companies Henderson Jeffrey William has filed insider reports for
- HALOZYME THERAPEUTICS, INC. (HALO): Director
- QUALCOMM INC/DE (QCOM): Director
- BECTON DICKINSON & CO (BDX): Director
Henderson Jeffrey William
CIK: 0001324015
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- May 5, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect3.8K shares- - Mar 17, 2026QCOM
QUALCOMM INC/DE
AwardDirect2.6K shares- - Mar 8, 2026QCOM
QUALCOMM INC/DE
DispositionDirect759 shares at avg. $135.69$103K - Mar 8, 2026QCOM
QUALCOMM INC/DE
ExerciseDirect2.4K shares- - Jan 27, 2026BDX
BECTON DICKINSON & CO
AwardDirect1.1K shares- - May 1, 2025HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect4.2K shares- - Apr 28, 2025HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect4.3K shares at avg. $60.34$259K - Apr 28, 2025HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect200 shares at avg. $60.99$12K - Apr 1, 2025HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect503 shares at avg. $64.05$32K - Mar 18, 2025QCOM
QUALCOMM INC/DE
AwardDirect2.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 5, 2026 |  HALO HALOZYME THERAPEUTICS, INC. | Award | 3,796 | - | $0 | Direct |
| Mar 17, 2026 |  QCOM QUALCOMM INC/DE | Award | 2,563 | - | $0 | Direct |
| Mar 8, 2026 | QCOM QUALCOMM INC/DE | Disposition | 759 | $135.69 | $102,989 | Direct |
| Mar 8, 2026 | QCOM QUALCOMM INC/DE | Exercise | 2,355 | - | $0 | Direct |
| Jan 27, 2026 |  BDX BECTON DICKINSON & CO | Award | 1,098 | - | $0 | Direct |
| May 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | Award | 4,165 | - | - | Direct |
| Apr 28, 2025 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 4,297 | $60.34 | $259,268 | Direct |
| Apr 28, 2025 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 200 | $60.99 | $12,199 | Direct |
| Apr 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 503 | $64.05 | $32,217 | Direct |
| Mar 18, 2025 | QCOM QUALCOMM INC/DE | Award | 2,097 | - | - | Direct |
1-10 of 18 transactions